Abstract
Objective To study the effect of mouse interferon-γ (mlFN-γ) insertion on the selective replication and cytotoxicity of a tumor-specific oncolytic adenovirus CNHK300 in hepatocellular carcinoma (HCC) cells and HCC xenografts. Methods The eytotoxicity of CNHK300-mlFN-γ (CNHK300- Mγ) was examined by methyl thiazol tetrazolium (MTT) calorimetric assay in normal and HCC ceils. Healthy nude BALB/C mice were injected with the SMMC-7221 cells. Forty mice with tumors of 5-8 mm in diameter were randomly divided into 4 groups of 10 mice : CNHK300-Mγ/group ( CNHK300-Mγ was injected into the tumor once every other day for 5 times), CNHK300 group (CNHK300 was injected) , ONYX- 015 group (ONYX-015 was injected), and control group (diluent of virus was injected). Seven, 14, 21, 28, 35, and 42 days after the initial injection the size of tumor was examined ( Tumor volume was estimated as a × b2 ×0. 5, where a and b were the maximal and minimal diameters, respectively). Forty-eighth after the finish of the whole course of treatment, the mice were killed. Twenty-four mice with the same tumors were randomly divided into 3 groups of 8 mice : CNHK300-Mr group, CHNK300 group and control group. The mice were killed in half, 3, 7 days after the last injection. Enzyme linked immunosorbent assay (ELISA) was used to detect the expression of mlFN-γ/in blood. Results CNHK300-M-γ could selectively kill tumor cell lines, whose 50% inhibitory concentration ( IC50 ) was under 1 in tumor cells and 370 in normal liver cells. ELISA showed that the expression of mlFN-γ in the blood of the CNHK300-Mγ group was (231 ± 101 ) ng/L or ( 1733 ± 191 ) ng/L in 3 days or 7 days after virus infection, while no mlFN-γ could be detected in CHNK300 group and control group. The tumor size in the CNHK300-Mr group was significantly smaller than in the CNHK300 group, ONYX-O15 group, and control group (P 〈 0. 05 ). Conclusion Being capable of specifically killed HCC ceils and mediating effective expression of therapeutic gene in vivo, CNHK3OO-Mγ holds a splendid future as a potential antitumor agent. Key words: Carcinoma,hepatocelhdar; Adenovirus; Telomerase; Gene therapy; Interferon-γ
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.